Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase 1 Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer Recruiting

2023-504361-23-00 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 2023-03-30
Study of Combination Therapies in Esophageal Cancer Recruiting

2023-505189-26-00 Advanced esophageal squamous cell carcinoma 9 2023-03-28
A study investigating the use of EP0031 in patients with cancers having an abnormal RET gene. Recruiting

2022-501636-42-00 Advanced RET-altered malignancies 9 2023-03-21
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF Class 1 and Class 2 alterations, in participan… Recruiting

2024-513578-23-00 Tumors harboring BRAF alterations 4 2023-03-21
Individualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM) Recruiting

2023-510214-11-00 Recurrent Glioblastoma 3 2023-03-21
Phase 2 trial of Translational approach to first line cHemoimmunotherapy followed by maintenance with pembrOlizumab and olaparib in Extensiv… Recruiting

2024-514666-39-00 Extensive-Stage Small-Cell Lung Cancer (ES SCLC) 4 2023-03-16
Clinical trial of androgen deprivation therapy combined with salvage radiotherapy when treating prostate cancer that has suffered recurrence… Recruiting

2024-517666-41-00 Prostate Cancer 5 2023-03-13
Study of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE) Recruiting

2023-507778-42-00 Non-Small Cell Lung Cancer II, III 4 2023-03-08
Evaluation of High-Intensity Focused Ultrasound (HIFU) Hemi-ablation and short-term androgen deprivation therapy combination to enhance pros… Recruiting

2024-518680-36-00 Intermediate risk prostate cancer 4 2023-03-07
(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a … Recruiting

2024-510766-16-00 Pancreatoduodenectomy with a high risk for contaminated 11 2023-03-06
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIA… Recruiting

2022-501894-37-00 prostate cancer 4 2023-03-02
A study of MP0533 in patients with blood cancer. Recruiting

2023-505259-39-00 Acute Myeloid Leukemia (AML) 7 2023-03-02
68Ga-SATO antagonist in neuroblastoma Recruiting

2024-513843-10-00 neuroblastoma 9 2023-02-28
Phase I/Ib clinical trial of PM54 in Advance Solid Tumors patients Recruiting

2023-508644-22-00 Advance Solid Tumors 7 2023-02-28
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into platinum/pemetrexed-based first-line treatment for epithelioid m… Recruiting

2024-515293-27-00 Malignant pleural mesothelioma, epithelioid subtype (st 4 2023-02-24
Efficacy and safety of the combination of Cisplatin plus Nab-paclitaxel and Nivolumab with radiotherapy after maximal tumor resection in non… Recruiting

2024-518937-26-00 Patients with non-metastatic muscle invasive bladder ca 4 2023-02-21
A Phase II Study to Evaluate the Imaging Potential of 68GaNOTA-Anti-MMR VHH2 for in Vivo Imaging of MMR-expressing Macrophages by Means of P… Recruiting

2024-514138-19-00 Patients with non-small cell lung cancer 4 2023-02-15
An open-label, multicentre, dose-escalation, first-in-human phase I study to evaluate safety, tolerability and antineoplastic activity of OA… Recruiting

2024-510836-31-00 Advanced and/or metastatic solid tumours (colorectal ca 1 2023-02-14
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants with Solid Cancers Treated with Cemiplimab Recruiting

2024-515351-37-00 Advanced Solid Tumor 1 2023-02-07
Phase I trial evaluating the tolerance of repeated opening of the bloodbrain barrier by ultrasound before chemotherapy in the treatment of r… Recruiting

2024-516169-35-00 recurrent primary supratentorial malignant brain tumors 7 2023-02-06
Chemotherapy for the treatment of standard risk adult medulloblastomas Recruiting

2024-513243-85-00 Adult medulloblastoma 4 2023-02-03
Immunotherapy in patients with early dMMR rectal cancer. A Danish DCCG phase II trial Recruiting

2022-500646-14-00 cancer 4 2023-01-31
A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid … Recruiting

2023-505065-91-00 Advanced or Metastatic Solid Tumors including EGFR-muta 4 2023-01-30
TRAK-ER_A randomised trial of early detection of molecular relapse with circulating tumour DNA tracking and treatment with palbociclib plus … Recruiting

2024-517414-15-00 ER positive HER2 negative breast cancer 4 2023-01-25